CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
8 hedge funds and large institutions have $11.4M invested in Celyad Oncology SA American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1K |
Top Sellers
1 |
Citadel Advisors
Miami,
Florida
|
-$35K |
2 |
Wells Fargo
San Francisco,
California
|
-$6.49K |
3 |
HF
HRT Financial
New York
|
-$6.01K |
4 |
Morgan Stanley
New York
|
-$171 |
5 |
UBS Group
Zurich,
Switzerland
|
-$10 |